Adline Chem Lab Ltd - 524604 - Compliances- PCS Certificate Under Regulation 40 (9) Of The SEBI (LODR), Regulations, 2015 For The Financial Year Ended 31St March, 2022
We are enclosing herewith PCS Certificate in terms of Reg. 40 of SEBI (LODR) Regulation, 2015 dated 8th April, 2022 certified by M/s. Kashyap R. Mehta & Associates, Company Secretaries for the year ended on 31st March, 2022. Adline Chem Lab Ltd - 524604 - Compliances- Compliance Certificate For The Period Ended March, 2022
Adline Chem Lab Limited hereby submits Certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations') for the financial year ended 31st March, 2022. Adline Chem Lab Ltd - 524604 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate issued by Link In time India Private Limited, Registrar and Share Transfer Agent of the Company for the Quarter ended on 31st March, 2022. Adline Chem Lab Ltd - 524604 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Kamlesh LaskariDesignation :- Managing Director / Whole Time Director Adline Chem Lab Ltd - 524604 - Closure of Trading Window
Pursuant to BSE's Circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and as per Clause 4 of the Schedule B and other applicable regulations of SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform you that in terms of Company's Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain closed w.e.f. 1st April, 2022 till 48 hours after the declaration of Audited Financial Results for the financial year ended on 31st March, 2022. KAMRON LABORATORIES LTD. - 524604 - Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 31St December, 2021.
KAMRON LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 31st December, 2021. KAMRON LABORATORIES LTD. - 524604 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per the Regulation 39(3) of the SEBI (LODR) Reg., 2015, we here with submit letter of RTA regarding details of loss of share certificate for your information and records. KAMRON LABORATORIES LTD. - 524604 - Shareholding for the Period Ended December 31, 2021
Kamron Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here KAMRON LABORATORIES LTD. - 524604 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate issued by Link In time India Private Limited, Registrar and Share Transfer Agent of the Company for the Quarter ended on 31st December, 2021. KAMRON LABORATORIES LTD. - 524604 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kamlesh J LaskariDesignation :- Managing Director / Whole Time Director